Newsroom

Sorted by: Latest
-

Playback Now Available for AM Best-Hosted Webinar on How AI, Agents and Human Expertise Are Reshaping Insurance Operations

OLDWICK, N.J.--(BUSINESS WIRE)--Video playback is now available for a complimentary webinar titled “AM Best's Informational Webinar – How AI, Agents and Human Expertise Are Reshaping Insurance Operations,” hosted by AM Best and sponsored by Xceedance. Access it here.In this one-hour webinar, a panel of insurance and technology experts shares practical insights, lessons learned and what it takes to move from AI pilots to measurable business impact.Panelists include:Arun Balakrishnan, chief execut...
-

Federal Court Rejects Keurig's Bid to End Antitrust Case; After 12 years of Litigation, Rogers Family Coffee Co. and Co-Plaintiffs’ Claims of Keurig’s Monopolization, Tying, and False Advertising Head to Trial

SAN FRANCISCO--(BUSINESS WIRE)--Federal Court Rejects Keurig's Bid to End Antitrust Case...
-

PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

NEW YORK--(BUSINESS WIRE)--Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law...
-

IFM Investors Announces Leadership Changes to Its Infrastructure Business in North America

HOUSTON--(BUSINESS WIRE)--IFM Investors today announced that Julio Garcia, Head of Infrastructure, North America, has advised of his intention to retire after more than 18 years with the firm. Garcia will step down from his executive responsibilities following a transition period. He will continue to contribute to IFM through his appointment to the Investment Committee, where his experience and expertise will remain an important asset to the business. IFM also announced that Michael Kulper will...
-

Samenvatting: Compvide kondigt commerciële lancering van CIMED aan en presenteert nieuw onderzoek tijdens European Meeting on Complement in Human Disease (EMCHD) 2026

SEATTLE--(BUSINESS WIRE)--Compvide, Inc. kondigt vandaag de commerciële lancering van zijn CIMED-platform aan. De CIMED-AP-, CIMED-LP- en CIMED-CP-kits evalueren respectievelijk de alternatieve, lectine- en klassieke complementroutes, waarbij gebruik wordt gemaakt van 50% serum om tests onder meer fysiologische omstandigheden mogelijk te maken. De commerciële lancering volgt op de deelname van Compvide aan de 20e European Meeting on Complement in Human Disease (EMCHD), die van 1 t/m 5 september...
-

Compvide annonce la mise sur le marché de CIMED et présente de nouveaux travaux de recherche lors de l'European Meeting on Complement in Human Disease (EMCHD) 2026

SEATTLE--(BUSINESS WIRE)--Compvide, Inc. a annoncé aujourd’hui la mise sur le marché de sa plateforme CIMED. Les kits CIMED-AP, CIMED-LP et CIMED-CP permettent d’évaluer, respectivement, les voies d'activation du complément (alterne, des lectines et classique), en utilisant du sérum à 50 % pour effectuer les tests dans des conditions plus physiologiques. Cette mise sur le marché fait suite à la participation de Compvide à la 20e édition de l’EMCHD (Conférence européenne sur le système du complé...
-

CCC Stock Notification: CCC Intelligent Solutions Inc. is being Investigated after the $7.75 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

NEW YORK--(BUSINESS WIRE)--CCC Intelligent Solutions Inc. is being Investigated after the $7.75 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law...
-

Corporate Shareholder Josh Pleitz Joins Munsch Hardt’s M&A Practice in Dallas

DALLAS--(BUSINESS WIRE)--Munsch Hardt has expanded its Corporate & Securities and M&A practices with the addition of shareholder Josh Pleitz in its Dallas office....
-

Antidote Health Expands into Texas and Georgia, Bringing Affordable Coverage and $0 Virtual Care to New ACA Shoppers

NEW YORK--(BUSINESS WIRE)--Antidote Health expands to Texas and Georgia for 2027 with ACA individual plans, plus small group coverage for Texas employers....
-

Resumen: Compvide anuncia el lanzamiento comercial de CIMED y presenta una nueva investigación en el Congreso Europeo de Complemento y Enfermedad Humana (EMCHD) 2026

SEATTLE--(BUSINESS WIRE)--Compvide, Inc. anunció hoy el lanzamiento comercial de su plataforma CIMED. Los kits CIMED-AP, CIMED-LP y CIMED-CP evalúan las vías alternativa, de las lectinas y clásica, respectivamente, con suero al 50 % para respaldar los ensayos bajo condiciones más fisiológicas. El lanzamiento comercial llega tras la participación de Compvide en el 20.º Congreso Europeo de Complemento y Enfermedad Humana (EMCHD), realizado del 1 al 5 de septiembre de 2026 en Cardiff (Gales). A tr...